SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis.
- DOI
- 10.2147/dmso.s628886
- Published
- 2026
- Container
- Diabetes, metabolic syndrome and obesity : targets and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/dmso.s628886,
title = {SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis.},
author = {Pan R and Wang B and Li Y and Li H and Liang X and Zhang Y and Liu X and Huang X and Wang R and Ji H and Zhao Y},
year = {2026},
journal = {Diabetes, metabolic syndrome and obesity : targets and therapy},
doi = {10.2147/dmso.s628886},
url = {https://doi.org/10.2147/dmso.s628886}
}RIS
TY - JOUR TI - SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis. AU - Pan R AU - Wang B AU - Li Y AU - Li H AU - Liang X AU - Zhang Y AU - Liu X AU - Huang X AU - Wang R AU - Ji H AU - Zhao Y PY - 2026 JO - Diabetes, metabolic syndrome and obesity : targets and therapy DO - 10.2147/dmso.s628886 UR - https://doi.org/10.2147/dmso.s628886 ER -
APA
R, P., B, W., Y, L., H, L., X, L., Y, Z., X, L., X, H., R, W., H, J., & Y, Z. (2026). SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis.. Diabetes, metabolic syndrome and obesity : targets and therapy. https://doi.org/10.2147/dmso.s628886
Source records
- pubmed · retrieved 2026-11-10T07:46:51.408Z